Lv1
40 积分 2024-09-23 加入
Constructing a metabolic integral score model for the quantification of metabolic dysfunction and tendency
17天前
已完结
Ixekizumab With or Without Tirzepatide in Adults With Psoriasis and Overweight or Obesity
1个月前
已关闭
Epidermolysis Bullosa Pruriginosa Treated With Upadacitinib
6个月前
已完结
Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in patients from China mainland, Taiwan, and South Korea with moderate to severe plaque psoriasis: a phase 3 randomized clinical trial
7个月前
已完结
Safety and Efficacy of Deucravacitinib in Moderate to Severe Plaque Psoriasis For Up to 3 Years
7个月前
已完结
Acneiform Eruption Secondary to Deucravacitinib: A Case Series and Review of the Literature
7个月前
已完结
Alopecia areata
8个月前
已完结
The impact of biologics targeting the IL-17 and IL-23 pathways on metabolic indicators in plaque psoriasis
8个月前
已完结
Compounds of psoriasis with obesity and overweight
8个月前
已关闭
0469 The association between bariatric surgery and improvement in psoriasis: A systematic review
8个月前
已关闭
皖公网安备34019202002308
